A migraine is not just a bad headache — it is a neurological disease that affects roughly one billion people worldwide and ranks among the leading causes of disability globally (Deen & Bhatt, 2022). For patients whose migraines have not responded to standard medications, the search for relief can stretch across years of failed trials, missed work, and diminishing quality of life. At Wholistic Health, we offer IV ketamine infusion therapy for migraines as part of our chronic pain treatment options — an approach grounded in how the nervous system processes and sustains pain.
Why Migraines Are a Neurological Problem, Not Just a Pain Problem
Understanding why ketamine may help with migraines starts with understanding what migraines actually are. A migraine episode involves complex changes in brain chemistry and neurological signaling — not simply a vascular event or tension in the head. Research into migraine pathophysiology has shown that the condition involves sensitization of pain-processing pathways in the brain, changes in neurotransmitter activity, and, in chronic cases, alterations in how the central nervous system perceives and amplifies pain signals (Deen & Bhatt, 2022).
This last point — central sensitization — is particularly important. In patients with chronic migraine, the brain’s pain system can become hypersensitive, meaning it responds to stimuli that would not normally provoke pain, or magnifies pain signals far beyond their actual intensity. This neurological re-calibration is part of why standard treatments often stop working over time, and why a different mechanism of action may be necessary.
Many patients with migraine also experience co-occurring depression or anxiety. Research consistently documents a bidirectional relationship between pain and mood disorders — each condition can drive and worsen the other, creating a cycle that is difficult to interrupt through single-symptom treatment alone (Sheng et al., 2017). To understand this connection more deeply, see our overview of how pain affects mental health. At Wholistic Health, we treat the whole person, which means we consider both dimensions when building a care plan.
How Ketamine Works for Migraine Relief
Ketamine is an anesthetic that was developed over 50 years ago and has since been studied extensively for its effects on pain and mood. Its relevance to migraine comes from its action on NMDA receptors — N-methyl-D-aspartate receptors — which play a central role in how the nervous system transmits and regulates pain signals. By blocking these receptors, ketamine can interrupt the central sensitization cycle that drives chronic migraine (Gorlin et al., 2016).
This mechanism is distinct from how most migraine medications work. Triptans and other standard migraine treatments primarily target acute episodes by affecting blood vessel tone or serotonin receptors. Ketamine acts on the deeper neurological architecture of the pain system — which is why it may offer relief in cases where surface-level interventions have not. For patients who have been through multiple medication trials without adequate response, this difference in mechanism can be meaningful. Learn more about our ketamine treatment approach and what the process involves.
It is important to be clear that ketamine is not FDA-approved specifically for migraine treatment. Its use for this indication is considered off-label — meaning it is used based on clinical evidence and provider judgment outside its formally approved indications. Our team at Wholistic Health reviews each patient’s history carefully before recommending any treatment, and we do not apply a one-size-fits-all protocol.
What Ketamine Infusion Therapy for Migraines Looks Like
For pain conditions at our clinic, ketamine is administered intravenously over a 2- to 4-hour session. The extended infusion time for pain protocols — compared to the 40-minute mental health infusion — reflects the different dosing approach required for neurological pain conditions. Our nurse practitioners monitor you throughout the session, and you remain awake.
The initial series for pain patients consists of 4 infusion days, which can be scheduled consecutively or on alternating days depending on your schedule and clinical needs. Some patients with more complex or long-standing pain conditions may benefit from a series of up to 10 consecutive sessions. After the initial series, patients enter a maintenance phase, returning for booster infusions as needed when symptoms begin to return.
A driver is required on the day of your infusion — you will not be cleared to drive yourself home, and we do not permit rideshare services for this purpose. We recommend scheduling treatments on days when you are not working and can rest afterward, though most patients return to normal function the following day.
Addressing the Cost Question
Ketamine infusion therapy for pain is a self-pay service. A 2-hour infusion is $600 and a 4-hour infusion is $800. We are straightforward about these numbers from the beginning, because we know cost is a genuine consideration for patients evaluating their options. Payment plans are available through Advance Care Card for patients who need to spread out the expense — our team walks through the financial details before you commit to anything.
For patients who have spent years pursuing migraine treatment through multiple specialists, medications, and ER visits, the cost of ketamine therapy can look different in that context. We do not tell patients what to spend or how to weigh their options — we give them honest information and let them make that decision for themselves.
Who May Benefit from Ketamine Infusion Therapy for Migraines
Patients most likely to be considered for ketamine infusion therapy for migraines are those who have not found adequate relief through standard migraine medications — triptans, preventive medications, CGRP inhibitors, or other prescribed treatments. Patients with frequent or chronic migraines, a history of central sensitization, or significant co-occurring mood symptoms may be particularly appropriate candidates for evaluation. Our broader innovative chronic pain management program addresses many of these overlapping conditions.
Ketamine is not appropriate for everyone. Patients with certain psychiatric histories, active substance use disorders, cardiovascular conditions, or other medical contraindications may not be candidates. Our consultation process is designed to identify these factors before any treatment decision is made, and we will always tell you honestly if we do not think ketamine is the right fit.
Stigma is something we encounter regularly with pain patients — the sense that their suffering has not been taken seriously, or that seeking out a treatment like ketamine carries judgment. At Wholistic Health, we do not approach pain that way. Chronic migraine is a legitimate neurological condition, and patients who have been through years of inadequate treatment deserve a clinical conversation that treats it as such.
Frequently Asked Questions
Is ketamine FDA-approved for migraines? Ketamine is not FDA-approved specifically for migraine treatment. Its use in this context is considered off-label — supported by clinical evidence and provider judgment. Our team at Wholistic Health evaluates each patient individually to determine whether ketamine is an appropriate option given their history and prior treatments.
How quickly does ketamine work for migraines? Many pain patients report some symptom relief after their first infusion series, though individual responses vary. The timeline and degree of relief depends on the severity and chronicity of the migraine condition, overall health, and other factors specific to each patient. We discuss realistic expectations during your consultation.
Will I need to stop my current migraine medications before treatment? In most cases, you continue your existing medications unless your provider advises otherwise. Ketamine therapy may allow some patients to reduce reliance on other medications over time, but any changes to your medication regimen should be made in collaboration with your prescribing provider.
How long does relief from ketamine infusion last for migraines? Duration of relief varies considerably from patient to patient. Some patients find relief lasting one to two months; others experience longer periods of improvement. Maintenance infusions are available as needed and are scheduled based on your individual response.
Does ketamine help with the depression that often accompanies chronic migraine? Ketamine has demonstrated rapid antidepressant effects in clinical research, and we recognize that many patients with chronic migraine also experience significant mood symptoms (Nature, 2021). Whether ketamine is appropriate for addressing both dimensions of your condition is something we evaluate during consultation.
Key Takeaways
- Migraine is a neurological disease involving central sensitization — not just acute pain — which is why treatments targeting the nervous system’s pain architecture may help where standard medications have not.
- Ketamine works by blocking NMDA receptors, interrupting the central sensitization cycle that sustains chronic migraine.
- IV ketamine for migraines is an off-label use, supported by clinical evidence, for patients who have not responded adequately to conventional migraine treatments.
- Pain protocol infusions at Wholistic Health run 2–4 hours; the initial series is 4 infusion days with maintenance boosters as needed.
- Results vary by individual — candidacy is determined through a thorough consultation that reviews your full treatment history and health status.
Chronic migraine can take over a life quietly — one cancelled plan, one lost workday, one darkened room at a time. If you have been through the standard treatment options without finding relief, IV ketamine infusion therapy may be worth discussing with our team. At Wholistic Health, we start with your history and build from there. Call us at 251-276-4185 or schedule a consultation to talk through whether ketamine therapy is an appropriate next step for you.
References
Deen, M., & Bhatt, D. (2022). Migraine — pathophysiology and treatment. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9506374/
Gorlin, A. W., Rosenfeld, D. M., & Ramakrishna, H. (2016). Intravenous sub-anesthetic ketamine for perioperative analgesia. Journal of Anaesthesiology Clinical Pharmacology, 32(2), 160–167. https://www.ncbi.nlm.nih.gov/books/NBK539824/
Sheng, J., Liu, S., Wang, Y., Cui, R., & Zhang, X. (2017). The link between depression and chronic pain: Neural mechanisms in the brain. Neural Plasticity. https://pmc.ncbi.nlm.nih.gov/articles/PMC5494581/
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine infusion therapy for migraines is an off-label use of ketamine and should only be pursued under the supervision of a qualified healthcare provider who has reviewed your full medical history. Individual results vary — not all patients will experience the same degree or duration of relief. This content is not intended to diagnose, treat, cure, or prevent any condition. Please consult a licensed provider before making any decisions about your treatment plan.